GH1 and neoplasm: A recent study on humans and mice demonstrated that disrupted GH signaling was associated with elevated p53 levels in colon tissue, suggesting GH may act as a tumor promoter by suppressing gene transcription of p53, PTEN, and APC levels (Chesnokova et al., 2016).